from pharmadata import pharmaverseadam
meta = pharmaverseadam.meta('adlb_neuro')
print(f"Rows: {meta.number_rows:,} Columns: {meta.number_columns}")Rows: 185 Columns: 48
adlb_neuro
Structure: One or more records per subject per analysis parameter per analysis visit
from pharmadata import pharmaverseadam
meta = pharmaverseadam.meta('adlb_neuro')
print(f"Rows: {meta.number_rows:,} Columns: {meta.number_columns}")Rows: 185 Columns: 48
| variable | label | type | mandatory | role |
|---|---|---|---|---|
| str | str | str | str | str |
| "STUDYID" | "Study Identifier" | "String" | "Yes" | "Identifier Variables for BDS Datasets" |
| "USUBJID" | "Unique Subject Identifier" | "String" | "Yes" | "Identifier Variables for BDS Datasets" |
| "DOMAIN" | "Domain Abbreviation" | "String" | "No" | null |
| "TRT01P" | "Planned Treatment for Period 01" | "String" | "No" | null |
| "TRT01A" | "Actual Treatment for Period 01" | "String" | "No" | null |
| "TRTSDT" | "Date of First Exposure to Treatment" | "Date" | "No" | "ADSL Treatment Timing Variables" |
| "TRTEDT" | "Date of Last Exposure to Treatment" | "Date" | "No" | "ADSL Treatment Timing Variables" |
| "ADT" | "Analysis Date" | "Date" | "No" | "Timing Variables for BDS Datasets" |
| "ADY" | "Analysis Relative Day" | "Float64" | "No" | "Timing Variables for BDS Datasets" |
| "AVISIT" | "Analysis Visit" | "String" | "No" | "Timing Variables for BDS Datasets" |
| "AVISITN" | "Analysis Visit (N)" | "Float64" | "No" | "Timing Variables for BDS Datasets" |
| "PARAM" | "Parameter" | "String" | "Yes" | "Analysis Parameter Variables for BDS Datasets" |
| "PARAMCD" | "Parameter Code" | "String" | "Yes" | "Analysis Parameter Variables for BDS Datasets" |
| "PARAMN" | "Parameter (N)" | "Float64" | "No" | "Analysis Parameter Variables for BDS Datasets" |
| "AVAL" | "Analysis Value" | "Float64" | "No" | "Analysis Parameter Variables for BDS Datasets" |
| "AVALC" | "Analysis Value (C)" | "String" | "No" | "Analysis Parameter Variables for BDS Datasets" |
| "ANRLO" | "Analysis Normal Range Lower Limit" | "Float64" | "No" | null |
| "ANRHI" | "Analysis Normal Range Upper Limit" | "Float64" | "No" | null |
| "BASE" | "Baseline Value" | "Float64" | "No" | "Analysis Parameter Variables for BDS Datasets" |
| "BASEC" | "Baseline Value (C)" | "String" | "No" | "Analysis Parameter Variables for BDS Datasets" |
| "BASETYPE" | "Baseline Type" | "String" | "No" | null |
| "CHG" | "Change from Baseline" | "Float64" | "No" | "Analysis Parameter Variables for BDS Datasets" |
| "PCHG" | "Percent Change from Baseline" | "Float64" | "No" | "Analysis Parameter Variables for BDS Datasets" |
| "ABLFL" | "Baseline Record Flag" | "String" | "No" | "Flag Variables for BDS Datasets" |
| "ANL01FL" | "Analysis Flag 01" | "String" | "No" | null |
| "ANL02FL" | "Analysis Flag 02" | "String" | "No" | null |
| "ONTRTFL" | "On Treatment Record Flag" | "String" | "No" | "Flag Variables for BDS Datasets" |
| "ASEQ" | "Analysis Sequence Number" | "Int32" | "No" | "Identifier Variables for BDS Datasets" |
| "LBSEQ" | "Sequence Number" | "Int32" | "No" | null |
| "LBTESTCD" | "Lab Test or Examination Short Name" | "String" | "No" | null |
| "LBTEST" | "Lab Test or Examination Name" | "String" | "No" | null |
| "LBCAT" | "Category for Lab Test" | "String" | "No" | null |
| "LBORRES" | "Result or Finding in Original Units" | "String" | "No" | null |
| "LBORRESU" | "Original Units" | "String" | "No" | null |
| "LBORNRLO" | "Reference Range Lower Limit in Orig Unit" | "String" | "No" | null |
| "LBORNRHI" | "Reference Range Upper Limit in Orig Unit" | "String" | "No" | null |
| "LBSTRESC" | "Character Result/Finding in Std Format" | "String" | "No" | null |
| "LBSTRESN" | "Numeric Result/Finding in Standard Units" | "Float64" | "No" | null |
| "LBSTRESU" | "Standard Units" | "String" | "No" | null |
| "LBSTNRLO" | "Reference Range Lower Limit-Std Units" | "Float64" | "No" | null |
| "LBSTNRHI" | "Reference Range Upper Limit-Std Units" | "Float64" | "No" | null |
| "LBNRIND" | "Reference Range Indicator" | "String" | "No" | null |
| "LBBLFL" | "Baseline Flag" | "String" | "No" | null |
| "VISITNUM" | "Visit Number" | "Float64" | "No" | null |
| "VISIT" | "Visit Name" | "String" | "No" | null |
| "VISITDY" | "Planned Study Day of Visit" | "Float64" | "No" | null |
| "LBDTC" | "Date/Time of Specimen Collection" | "String" | "No" | null |
| "LBDY" | "Study Day of Specimen Collection" | "Float64" | "No" | null |
from great_docs import tbl_explorer
from pharmadata import pharmaverseadam
tbl_explorer(pharmaverseadam.adlb_neuro.head(10))PolarsRows10Columns48 | ||||||||||||||||||||||||||||||||||||||||||||||||
STUDYID str |
USUBJID str |
DOMAIN str |
TRT01P str |
TRT01A str |
TRTSDT date |
TRTEDT date |
ADT date |
ADY f64 |
AVISIT str |
AVISITN f64 |
PARAM str |
PARAMCD str |
PARAMN f64 |
AVAL f64 |
AVALC str |
ANRLO f64 |
ANRHI f64 |
BASE f64 |
BASEC str |
BASETYPE str |
CHG f64 |
PCHG f64 |
ABLFL str |
ANL01FL str |
ANL02FL str |
ONTRTFL str |
ASEQ i32 |
LBSEQ i32 |
LBTESTCD str |
LBTEST str |
LBCAT str |
LBORRES str |
LBORRESU str |
LBORNRLO str |
LBORNRHI str |
LBSTRESC str |
LBSTRESN f64 |
LBSTRESU str |
LBSTNRLO f64 |
LBSTNRHI f64 |
LBNRIND str |
LBBLFL str |
VISITNUM f64 |
VISIT str |
VISITDY f64 |
LBDTC str |
LBDY f64 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | CDISCPILOT01 | 01-701-1015 | LB | Placebo | Placebo | 2014-01-02 | 2014-07-02 | 2014-01-02 | 1 | Baseline | 0 | Lumipulse G Beta-Amyloid 1-42-N Plasma (pg/mL) | AMYLB42 | 2 | 1120.31075459 | None | None | None | 1120.31075459 | None | LAST | None | None | Y | Y | Y | None | 1 | 2 | AMYLB42 | Lumipulse G Beta-Amyloid 1-42-N Plasma | Biomarkers | 1120.3 | pg/mL | None | None | 1120.3 | 1120.31075459 | pg/mL | None | None | None | Y | 0 | BASELINE | 1 | 2014-01-02 | 1 |
| 1 | CDISCPILOT01 | 01-701-1015 | LB | Placebo | Placebo | 2014-01-02 | 2014-07-02 | 2014-03-26 | 84 | Week 12 | 12 | Lumipulse G Beta-Amyloid 1-42-N Plasma (pg/mL) | AMYLB42 | 2 | 730.667401068 | None | None | None | 1120.31075459 | None | LAST | -389.643353522 | -34.779935114 | None | Y | None | Y | 2 | 7 | AMYLB42 | Lumipulse G Beta-Amyloid 1-42-N Plasma | Biomarkers | 730.7 | pg/mL | None | None | 730.7 | 730.667401068 | pg/mL | None | None | None | None | 12 | WEEK 12 | 84 | 2014-03-26 | 84 |
| 2 | CDISCPILOT01 | 01-701-1015 | LB | Placebo | Placebo | 2014-01-02 | 2014-07-02 | 2014-07-02 | 182 | Week 26 | 26 | Lumipulse G Beta-Amyloid 1-42-N Plasma (pg/mL) | AMYLB42 | 2 | 257.161938772 | None | None | None | 1120.31075459 | None | LAST | -863.148815818 | -77.0454815579 | None | Y | Y | Y | 3 | 11 | AMYLB42 | Lumipulse G Beta-Amyloid 1-42-N Plasma | Biomarkers | 257.2 | pg/mL | None | None | 257.2 | 257.161938772 | pg/mL | None | None | None | None | 26 | WEEK 26 | 182 | 2014-07-02 | 182 |
| 3 | CDISCPILOT01 | 01-701-1015 | LB | Placebo | Placebo | 2014-01-02 | 2014-07-02 | 2013-12-29 | -4 | Baseline | 0 | Alpha Synuclein Seed Amplification Assay (CSF) | ASYNASAA | 4 | 1 | Positive | None | None | 1 | Positive | LAST | None | None | Y | Y | Y | None | 4 | 5 | ASYNASAA | Alpha Synuclein Seed Amplification Assay (CSF) | Biomarkers | Positive | None | None | None | Positive | 1 | None | None | None | None | Y | 3 | BASELINE | -3 | 2013-12-29 | -3 |
| 4 | CDISCPILOT01 | 01-701-1015 | None | Placebo | Placebo | 2014-01-02 | 2014-07-02 | 2014-01-02 | 1 | Baseline | 0 | Log-Transformed Lumipulse G Beta-Amyloid 1-42-N Plasma (pg/mL) | LAMYLB42 | 6 | 7.02136138526 | None | None | None | None | None | None | None | None | None | None | None | None | 5 | None | None | None | None | None | None | None | None | None | None | None | None | None | None | None | None | None | None | None | None |
| 5 | CDISCPILOT01 | 01-701-1015 | None | Placebo | Placebo | 2014-01-02 | 2014-07-02 | 2014-03-26 | 84 | Week 12 | 12 | Log-Transformed Lumipulse G Beta-Amyloid 1-42-N Plasma (pg/mL) | LAMYLB42 | 6 | 6.59395836451 | None | None | None | None | None | None | None | None | None | Y | None | Y | 6 | None | None | None | None | None | None | None | None | None | None | None | None | None | None | None | None | None | None | None | None |
| 6 | CDISCPILOT01 | 01-701-1015 | None | Placebo | Placebo | 2014-01-02 | 2014-07-02 | 2014-07-02 | 182 | Week 26 | 26 | Log-Transformed Lumipulse G Beta-Amyloid 1-42-N Plasma (pg/mL) | LAMYLB42 | 6 | 5.54970599841 | None | None | None | None | None | None | None | None | None | Y | Y | Y | 7 | None | None | None | None | None | None | None | None | None | None | None | None | None | None | None | None | None | None | None | None |
| 7 | CDISCPILOT01 | 01-701-1015 | LB | Placebo | Placebo | 2014-01-02 | 2014-07-02 | 2014-01-02 | 1 | Baseline | 0 | Lumipulse G pTau 217/Beta-Amyloid 1-42 Plasma Ratio | PTAB42R | 3 | 0.00735273053814 | None | 0.0037 | 0.00738 | 0.00735273053814 | None | LAST | None | None | Y | Y | Y | None | 8 | 3 | PTAB42R | Lumipulse G pTau 217/Beta-Amyloid 1-42 Plasma Ratio | Biomarkers | 0.00735 | None | 0.00370 | 0.00738 | 0.00735 | 0.00735273053814 | None | 0.0037 | 0.00738 | Indeterminate | Y | 0 | BASELINE | 1 | 2014-01-02 | 1 |
| 8 | CDISCPILOT01 | 01-701-1015 | LB | Placebo | Placebo | 2014-01-02 | 2014-07-02 | 2014-03-26 | 84 | Week 12 | 12 | Lumipulse G pTau 217/Beta-Amyloid 1-42 Plasma Ratio | PTAB42R | 3 | 0.00832766541628 | None | 0.0037 | 0.00738 | 0.00735273053814 | None | LAST | 0.00097493487814 | 13.259494185 | None | Y | None | Y | 9 | 8 | PTAB42R | Lumipulse G pTau 217/Beta-Amyloid 1-42 Plasma Ratio | Biomarkers | 0.00833 | None | 0.00370 | 0.00738 | 0.00833 | 0.00832766541628 | None | 0.0037 | 0.00738 | Positive | None | 12 | WEEK 12 | 84 | 2014-03-26 | 84 |
| 9 | CDISCPILOT01 | 01-701-1015 | LB | Placebo | Placebo | 2014-01-02 | 2014-07-02 | 2014-07-02 | 182 | Week 26 | 26 | Lumipulse G pTau 217/Beta-Amyloid 1-42 Plasma Ratio | PTAB42R | 3 | 0.00394371593774 | None | 0.0037 | 0.00738 | 0.00735273053814 | None | LAST | -0.00340901460039 | -46.3639267441 | None | Y | Y | Y | 10 | 12 | PTAB42R | Lumipulse G pTau 217/Beta-Amyloid 1-42 Plasma Ratio | Biomarkers | 0.00394 | None | 0.00370 | 0.00738 | 0.00394 | 0.00394371593774 | None | 0.0037 | 0.00738 | Indeterminate | None | 26 | WEEK 26 | 182 | 2014-07-02 | 182 |